NOVARTIS N (NOT.SG) (NOT STU) stock market data APIs
€103.0187
1.51(1.5%)
as of July 14, 2025
Try our APIs with
free plan!
NOVARTIS N (NOT.SG) Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for NOT.SG.
Prev. Close
103.0187
Open
104.5299
High
104.5299
Low
103.2426
52 wk Range
71.4774-105.8
Market Cap
160 075 M
Dividends (Yield)
0.0488
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get NOVARTIS N (NOT.SG) data using free add-ons & libraries
Get NOVARTIS N (NOT.SG) Fundamental Data
NOVARTIS N (NOT.SG) Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-17
- EPS/Forecast: 2.37
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
NOVARTIS N (NOT.SG) News
New
Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke
European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S. investment. The $200 billion pharma company intends to invest $23...
Stocks to Watch Friday: JPMorgan, Novartis, BYD
🔎 JP Morgan (JPM), BlackRock (BLK), Morgan Stanley (MS), and Wells Fargo (WFC) are set to report earnings before the bell. ↗️ Novartis (CH:NOVN, NVS): Shares of the Swiss drug maker rose more t...
Novartis Stock Rises After Swiss Drugmaker Promises to Boost U.S. Manufacturing
A Swiss drug giant has gotten the message from President Trump’s tariff threats. Novartis said Thursday it will spend $23 billion over the next five years to expand its footprint in the U.S. The com...
Swiss Drugmaker Novartis Promises to Boost U.S. Manufacturing Amid Tariff Threats
A Swiss drug giant has gotten the message from President Trump’s tariff threats. Novartis said Thursday it will spend $23 billion over the next five years to expand its footprint in the U.S. The com...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
